DUBLIN, Dec. 11, 2014 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/2r6bmg/drug_injection) has announced the addition of the "Drug Injection Devices to 2020" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

As new drugs become available for the treatment of an expanding list of health conditions, drug developers have increasingly pursued packaging and delivery options that simplify the administration process and increase the efficiency and reliability with which the drug can be introduced into the patient. For injectable drugs, this pursuit has led to an accelerated evolution in injection device design, creating new opportunities and choices for drug designers and marketers.

The injectable device sector today consists of a half-dozen established device classes and two emerging classes. For the remainder of the decade, pipeline drugs and shifting demographics will drive sector growth as an aging population of baby boomers (23% of US population) provides stimulus for industry demand. Currently, the over 65 segment accounts for approximately 13% of the US population, with an estimated 40% of total healthcare expenditures, but by 2020, this segment is expected to grow to 17% of the population.

This aging of the population will predominately benefit products that can be used by the elderly.This report examines the key therapeutic, product, market and regulatory factors for injection devices, providing essential insight and forecasts into the implications of this evolving landscape.

Highlights

• Analyzes and evaluates the shifting landscape for syringes and injection devices and assesses the market impact of new and evolving devices by therapeutic indication
• Analyzes syringe and injector device designs, feature/functionality, product branding, competing technologies and market development issues
• Provides detailed descriptions of key injectable device therapeutic market segments, market demographics, and business strategies
• Forecasts syringe and injection device demand by indication and therapy to 2020
• Profiles leading injection device companies, their product development activities, business strategies, and corporate alliances and affiliations

Key Topics Covered:

1. Executive Summary
2. Drug Injection Device Market Dynamics
3. Evolution in Injectable Drug Development
4. Injectable Drug Demand Drivers
5. Diseases and Indications
6. Syringe Economics
7. Chronic Conditions & Self-Administration
8. Technology Factors
9. Device Selection Factors
10. Market Segmentation
11. Product Features & Ease of Use
12. Competitive Landscape
13. Injection Device Suppliers
14. Capabilities and Market Presence
15. Technology and Infrastructure
16. Market Success Factors
17. Injection Devices
18. Autoinjectors
19. Dual Chamber Syringes
20. Needle-free Injectors
21. Pen Injectors
22. Prefilled Syringes
23. Safety Syringes
24. Emerging Device Classes
25. Wearable Injectors
26. Patch Pumps
27. Large Volume wearable Injectors
28. Risks and Opportunities
29. Injection Device Selection Criteria
30. Stability and Material Selection Issues
31. Single vs Multi-Dose Devices
32. Fixed vs Variable Dose Devices
33. Lyophilized Drugs/Reconstitution
34. Syringe Safety/Sharps Protection
35. Needle Configuration Strategies
36. Disposable Drug Cartridges
37. Human Engineering/Ergonomics
38. Branding/Private Labeling
39. Drug Delivery Devices - Device Classes and Analysis
40. Autoinjectors
41. Autoinjector Device Categories
42. Reusable Autoinjectors
43. Disposable Autoinjectors
44. Product Specific Autoinjectors
45. Autoinjector-specific Selection Factors
46. Safety Features
47. Needle Shielding
48. Needle Insertion Depth
49. Failsafe Activation
50. Dose Inspection/Injection Confirmation
51. Device Evolution and Market Impact
52. Dual Chamber Syringes
53. Needle-free Injectors
54. Device Categories
55. End User/Practitioner/Mass Immunization Injectors
56. Prefilled Disposable Models
57. Refillable Cartridge Designs
58. Needle-free Injector-specific Selection Factors
59. Energy Source/Injection Site Selection
60. Injection Site Selection
61. Needle-free Injectors - the Next Six Years
62. Pen Injectors
63. Recent Segment Evolution and Product Consolidation
64. Pen Design and Device Selection
65. Standardized Pen Platforms
66. Custom Pen Designs
67. Pen Classes
68. Reusable Pens
69. Disposable Pens
70. Dual Chamber Pens
71. Pen Injector Evolution and Growth
72. Prefilled Syringes
73. Prefilled Syringe Device Categories
74. Glass Prefilled Syringes
75. Plastic Prefilled Syringes
76. Prefillable Safety Syringes
77. Prefilled Syringe Selection Factors
78. Ready to Fill Prefillable Syringes
79. Fill-and-Finish CSO Selection
80. PFS Trending and Evolution - the Next Six Years
81. Safety Syringes
82. Safety Syringe Device Categories
83. Integrated Safety Syringes
84. Automatic Safety Mechanism
85. Manual Safety Mechanism
86. Post Manufacture Add-on/Bolt-on Safety Mechanisms
87. Safety Syringes - Market Evolution and Segment Expectations
88. Wearable Injectors
89. Patch Pumps
90. Large Volume Wearable Injectors
91. Drug Injection Device Market Segment Analysis & Forecasts
92. Anaphylaxis
93. Anticoagulants
94. Antivirals
95. Autoimmune Diseases
96. Diabetes
97. Emergency Medicine
98. Hematopoietics
99. Hormone Replacement
100. Neurology
101. Osteoporosis
102. Reproductive Health
103. Vaccines
104. Injectable Drug Therapeutics - Market Factors
105. Regulatory Factors and Issues
106. FDA Regulations
107. Regulating Combination Products
108. Sharps Legislations
109. Growth and Diversity of Safety Syringes
110. Sharps Disposal
111. Managed Care and Healthcare Economics
112. Company Profiles

For more information visit http://www.researchandmarkets.com/research/2r6bmg/drug_injection

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets